Literature DB >> 26063634

St Gallen International Expert Consensus on the primary therapy of early breast cancer: an invaluable tool for physicians and scientists.

M Ignatiadis1, M Buyse2, C Sotiriou3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26063634     DOI： 10.1093/annonc/mdv259

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

1.  Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.

Authors:  Fangxuan Li; Yang Zhao; Lijuan Wei; Shixia Li; Juntian Liu
Journal:  Cancer Biol Ther       Date:  2018-05-08       Impact factor: 4.742

2.  Young age at diagnosis is associated with worse prognosis in the Luminal A breast cancer subtype: a retrospective institutional cohort study.

Authors:  Zhiyang Liu; Zeyad Sahli; Yongchun Wang; Antonio C Wolff; Leslie M Cope; Christopher B Umbricht
Journal:  Breast Cancer Res Treat       Date:  2018-09-17       Impact factor: 4.872

3.  Indoleamine-2,3-dioxygenase and Interleukin-6 associated with tumor response to neoadjuvant chemotherapy in breast cancer.

Authors:  Fangxuan Li; Lijuan Wei; Shixia Li; Juntian Liu
Journal:  Oncotarget       Date:  2017-11-01

4.  Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer.

Authors:  Yun Yeong Kim; Se Jeong Oh; Yong Soon Chun; Woon Kee Lee; Heung Kyu Park
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

5.  Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer.

Authors:  Soomin Ahn; Hyun Jeong Kim; Milim Kim; Yul Ri Chung; Eunyoung Kang; Eun-Kyu Kim; Se Hyun Kim; Yu Jung Kim; Jee Hyun Kim; In Ah Kim; So Yeon Park
Journal:  Cancer Res Treat       Date:  2018-01-24       Impact factor: 4.679

6.  Value of digital mammography in predicting lymphovascular invasion of breast cancer.

Authors:  Zhuangsheng Liu; Ruqiong Li; Keming Liang; Junhao Chen; Xiangmeng Chen; Xiaoping Li; Ronggang Li; Xin Zhang; Lilei Yi; Wansheng Long
Journal:  BMC Cancer       Date:  2020-04-03       Impact factor: 4.430

7.  The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer: study protocol for a randomized controlled trial.

Authors:  Yajie Ji; Siyu Li; Xinyue Zhang; Yu Liu; Qing Lu; Qiong Li; Weili Chen; Jiayu Sheng; Ke Jiang; Hongli Liang; Shanyan Sha; Mengting Li; Zongxin Chen; Peiyi Zheng; Minhong Wang; Yuanyuan Feng; Lei Wang; Huangan Wu; Huirong Liu; Yan Huang; Zhiguang Yin; Xiaohong Xue
Journal:  Trials       Date:  2020-10-12       Impact factor: 2.279
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.